GILEAD SCIENCES, INC.
CIK 882095 · EDGAR ↗
- sum of disclosed values for 2026-03-31; 0 positions have no disclosed value and are left out of the sum, counted here rather than dropped
- $2.1B
- every reported holding for this filer and quarter, including ones with no disclosed value
- 6
- positions with no comparable holding in the prior quarter (kind new), 2026-03-31
- 0
- positions absent from this quarter's filing after being held last quarter (kind exit), 2026-03-31 — inferred from absence, not a sale record
- 0
Quarter-end snapshot, filed up to 45 days later — not current holdings. What a 13F covers ↓
Changes · Quarter ended 2026-03-31. Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt.
by shares · How classified ↗Period
Every row below carries cusip-reconciled — stated once here rather than repeated on every row.
| position matched across quarters by exact reported CUSIP over a registry gap — never a name match | NEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE | derived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zero | Prev value | Curr value | Prev shares | Curr shares | |
|---|---|---|---|---|---|---|---|
share class as filed: COM · position key cusip:98422T100 · issuer key cusip6:98422T‡r | TRIM | −$360K | −8,455,062 | $5.8M | $5.5M | 9,105,451 | 650,389 |
Ticker: no position here maps to a reviewed ticker. Flags: every row carries cusip-reconciled, stated once above the table.
Mark-to-market only (no share change) · 5
Positions whose share count is identical in both quarters; the value changed with price, not with a decision.
| position matched across quarters by exact reported CUSIP over a registry gap — never a name match | NEW / ADD / TRIM / EXIT by share count · NO CHANGE = same shares; the value moved with price, so never an ADD or a TRIM · EXIT = absent this quarter (disposed, delisted, confidential, or reported by an affiliate) — the filing does not say which · NO PRIOR = no comparable prior quarter on record (a first filing, or a quarter filed inside an affiliate's report), so not called a new stake · n/c = not classifiable: value undisclosed on one side of the pair, or neither shares nor value can classify it · †v: the reported share count is unchanged across the pair; this build's data classified the change from its reported value; builds from 2026-09-10 on read it as NO CHANGE | derived by Public Filings from the published data; “no value” means the source did not disclose a usable value — never zero | Prev value | Curr value | Prev shares | Curr shares | |
|---|---|---|---|---|---|---|---|
share class as filed: COM · position key sid:sec:prov:45fc32dac56f2bd3e501273f0a0a1e4d · issuer key cusip6:03940C | NO CHANGE | +$333M | 0 | $438M | $772M | 6,720,803 | 6,720,803 |
share class as filed: COM · position key sid:sec:prov:3c51cfeec4a5be695bdb08ebfaa41e00 · issuer key cusip6:03969F | NO CHANGE | −$70.1M | 0 | $749M | $679M | 31,424,760 | 31,424,760 |
share class as filed: SPON ADR · position key sid:sec:prov:856d00daa392df84ca63299ef03992d5 · issuer key cusip6:36315X | NO CHANGE | −$49.4M | 0 | $551M | $501M | 16,707,477 | 16,707,477 |
share class as filed: COM NEW · position key pos:17554 · issuer key iss:2344 | NO CHANGE | −$28.2M | 0 | $153M | $125M | 4,505,391 | 4,505,391 |
share class as filed: COM · position key sid:sec:prov:025f5bfc45d0f21f39b99aeb6192bfc1 · issuer key cusip6:501976 | NO CHANGE | −$3.2M | 0 | $38.8M | $35.6M | 4,126,119 | 4,126,119 |
Ticker: no position here maps to a reviewed ticker. Flags: no row carries a flag.
Holdings without a security ID are counted, not compared. Method ↗
Reported positions — 2026-03-31
6 positionsViewThis build carries one quarter for this manager: 2026-03-31. Notable managers carry four published quarters, others two.
Every row below carries ticker not yet mapped — stated once here rather than repeated on every row.
| a position composed from a base filing plus NEW-HOLDINGS amendments keeps every source row here; the composition's latest filed date is the one shown served from this build's published holdings (derived from the filer's own reported rows); every row resolves to its filing | Share of total reported value, calculated only when the full position list has disclosed values. This is 13F long value, not total assets. | value undisclosed on the filing: retained and counted, excluded from sums, never shown as $0 | Shares | Wt |
|---|---|---|---|---|
| Arcellx Inc · COM CUSIP 03940C100 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $772M | 6,720,803 | 36.4% | |
| Arcus Biosciences Inc · COM CUSIP 03969F109 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $679M | 31,424,760 | 32.1% | |
| Galapagos NV · SPON ADR CUSIP 36315X101 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $501M | 16,707,477 | 23.7% | |
| Assembly Biosciences Inc · COM NEW CUSIP — quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $125M | 4,505,391 | 5.9% | |
| Kyverna Therapeutics Inc · COM CUSIP 501976104 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $35.6M | 4,126,119 | 1.7% | |
| Xilio Therapeutics Inc · COM CUSIP 98422T100 quarter ended 2026-03-31 filed filed 2026-05-08 +38d | $5.5M | 650,389 | 0.3% |
Ticker: no reported row here maps to a reviewed ticker.
1–6 of 6 positions · page 1 of 1
One line per issuer, largest first — open a line for its reported rows. Grouping ↗
Book shape
Tick = median of the 8,748 tracked filers with a 2026-03-31 book (the index median: the 8,662 with a complete book). Concentration uses reported 13F long value, not total assets; the index is withheld when any position lacks a value.- 100.0%above median 80.0%
- integer Herfindahl–Hirschman index in basis points over disclosed position values
- 2,952 bpsabove median 446 bps
- holdings with no disclosed value (undisclosed, or unreadable on the filing) — kept and counted, never shown as zero
- 6 / 6median book 97.5 positions
6 quarter-over-quarter rows
Filing history
| Period | Source |
|---|---|
| 2026-03-31 | EDGAR ↗ |
Complete source filings on SEC EDGAR
The filing on EDGAR is the record, including any filed after this build.
Open GILEAD SCIENCES, INC.'s 13F filings on SEC EDGAR ↗A 13F is a quarterly, long-only snapshot filed up to 45 days late — not current holdings. what a 13F covers ↗
13F reports cover LONG positions in Section 13(f) securities (US exchange-traded equities plus reportable options, warrants, certain convertibles) held by managers with at least $100M in such securities — so managers below that threshold are absent entirely. No short positions, no cash, no non-13(f) assets — not a full portfolio, and not a census of institutional ownership.
Positions are quarter-end snapshots filed up to 45 days late — not current holdings: a position may have changed or closed since the quarter ended.
Values are the manager's stated market value at quarter-end in era-dependent units (whole dollars for form versions effective 2023-01-03 onward, thousands before), normalized here to whole dollars; each record notes its original unit.
Affiliated managers may report the same position, so one position can appear under more than one filer.
Positions under confidential treatment may be omitted until a later amendment discloses them.
These are disclosures, not investment advice.